| Name | Title | Contact Details |
|---|
AngioDynamics (was Diomed Ltd) Holdings, Inc. is a Andover, MA-based company in the Business Services sector.
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
Tsl is a Covington, GA-based company in the Business Services sector.
Ilera strives to drive medical advancements and shape the future of medical marijuana-based therapies in the Commonwealth of Pennsylvania.
Sonesta Resorts St. Maarten feature a duo of stunning oceanfront all-inclusive properties including the family Sonesta Maho Beach Resort, Casino & Spa, and the luxury, all suites adults-only Sonesta Ocean Point Resort. Both properties boast several dining options, pools, extensive wedding, events and meeting facilities, live entertainment, Casino Royale and a signature Serenity Spa accompanied by other resorts facilities such as Ocean Breeze gift shop, Nexus tour desk, Dollar/Thrifty car rental and state of the art gym with dedicated fitness and well-being program.